Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Treating multiple infections

Unique parasite study finds treatment shortcomings

A recent study of wild mice has suggested that the use of drugs to treat an infection, could allow co-existing conditions to flourish.

Researchers from the University of Edinburgh treated wild wood mice for a gut worm infection over the course of several weeks.

Scientists monitored levels of the worm during the course of the treatment, and tested the mice for several other common parasite infections.

Whilst the treatment lowered the levels of the gut worm, researchers found that levels of other parasites in the gut increased.

The research suggests that where infections co-exist, the treatment of one may allow the others to thrive, even to the detriment of overall health.

Dr Amy Pedersen of the university's School of Biological Sciences, said: "In nature, infections rarely occur by themselves, and this study shows for the first time that treating infections in isolation can have knock-on effects for other diseases that may be present.

"More work is needed to understand the effect of drug treatment for disease where individuals are prone to, or likely to be carrying a range of infections."

The research was carried out in collaboration with the University of Liverpool, and has been published in the Proceedings of the Royal Society B.

Image: Wood mouse, © Hans Hillewaert / CC-BY-SA-3.0

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.